Food and Drug Administration - Debarment List
The Food and Drug Administration (FDA) Debarment List identifies individuals and organizations that have been barred from participating in FDA-related activities.
Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
303 Entities in Food and Drug Administration - Debarment List
Entity Name | Entity Type | Effective Date | Status |
---|---|---|---|
James Michael Anthony | Individual | Nov 7, 1997 | active |
Paul S Singh | Individual | Nov 15, 2016 | active |
Analay Rico | Individual | Jun 8, 2023 | active |
Raju Vegesna | Individual | Apr 12, 1993 | active |
Yvelice VillamanBencosme | Individual | Apr 19, 2022 | active |
Jason Vale | Individual | Jan 12, 2010 | active |
Hassan Tahsildar | Individual | Feb 8, 2023 | inactive |
Edmund J Striefsky | Individual | Sep 30, 2003 | active |
Wayne E Spencer | Individual | Sep 13, 2012 | active |
Jerrod Nichols Smith | Individual | Jan 4, 2021 | active |
FAQs
Why is compliance with Food and Drug Administration - Debarment List necessary?
Compliance with the Food and drug administration (fda) debarment list is essential for several reasons. first and foremost, it helps ensure the safety and effectiveness of food and drug products. the fda maintains this list to identify individuals or companies that have been barred from participating in fda-related activities due to serious violations, such as fraud or misconduct. by checking this list, compliance professionals can prevent their organizations from engaging with parties that may compromise product integrity.
Which companies should comply with Food and Drug Administration - Debarment List?
The Food and Drug Administration (FDA) debarment list affects companies in the pharmaceutical, biotechnology, and food industries. Organizations in these sectors must comply to ensure the safety and efficacy of their products. Being aware of this list helps maintain regulatory standards and protects public health by preventing individuals with a history of misconduct from participating in vital regulatory processes.
APIs
Data License
Solutions
Pricing